Year |
Citation |
Score |
2019 |
Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M, Hwang EI, Gururangan S, Hansford JR, Fouladi M, Nobusawa S, Laquerriere A, Delisle MB, Fangusaro J, Forest F, ... ... Rousseau A, et al. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathologica. PMID 31820118 DOI: 10.1007/S00401-019-02111-Y |
0.36 |
|
2019 |
Boisseau W, Euskirchen P, Mokhtari K, Dehais C, Touat M, Hoang-Xuan K, Sanson M, Capelle L, Nouet A, Karachi C, Bielle F, Guégan J, Marie Y, Martin-Duverneuil N, Taillandier L, ... Rousseau A, et al. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations. The Oncologist. PMID 31346129 DOI: 10.1634/Theoncologist.2019-0223 |
0.34 |
|
2018 |
Siegfried A, Rousseau A, Maurage CA, Pericart S, Nicaise Y, Escudie F, Grand D, Delrieu A, Gomez-Brouchet A, Le Guellec S, Franchet C, Boetto S, Vinchon M, Sol JC, Roux FE, et al. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity. Brain Pathology (Zurich, Switzerland). PMID 29679497 DOI: 10.1111/Bpa.12619 |
0.362 |
|
2018 |
Li B, Vasiljevic A, Ho B, Norman J, Lu M, Hwang E, Hansford J, Jouvet A, Laquerriere A, Delisle M, Gururangan S, Fangusaro J, Forest F, Sumihito N, Toledano H, ... ... Rousseau A, et al. Embr-17. Pineoblastoma Segregates Into Molecular Subtypes With Distinct Clinicopathologic Features: Report From The Rare Brain Tumor Consortium Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.201 |
0.338 |
|
2017 |
Bielle F, Di Stefano AL, Meyronnet D, Picca A, Villa C, Bernier M, Schmitt Y, Giry M, Rousseau A, Figarella-Branger D, Maurage CA, Uro-Coste E, Lasorella A, Iavarone A, Sanson M, et al. Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features. Brain Pathology (Zurich, Switzerland). PMID 28976058 DOI: 10.1111/Bpa.12563 |
0.352 |
|
2017 |
Terrier LM, Bauchet L, Rigau V, Amelot A, Zouaoui S, Filipiak I, Caille A, Almairac F, Aubriot-Lorton MH, Bergemer-Fouquet AM, Bord E, Cornu P, Czorny A, Dam Hieu P, Debono B, ... ... Rousseau A, et al. Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database. Neuro-Oncology. 19: 678-688. PMID 28453747 DOI: 10.1093/Neuonc/Now186 |
0.356 |
|
2017 |
Breton Q, Plouhinec H, Prunier-Mirebeau D, Boisselier B, Michalak S, Menei P, Rousseau A. BRAF-V600E immunohistochemistry in a large series of glial and glial-neuronal tumors. Brain and Behavior. 7: e00641. PMID 28293477 DOI: 10.1002/Brb3.641 |
0.326 |
|
2017 |
De Carli E, Delion M, Rousseau A. [Immunotherapy in brain tumors]. Annales De Pathologie. PMID 28111040 DOI: 10.1016/J.Annpat.2016.12.001 |
0.35 |
|
2016 |
Cikankowitz A, Clavreul A, Tétaud C, Lemaire L, Rousseau A, Lepareur N, Dabli D, Bouchet F, Garcion E, Menei P, Couturier O, Hindré F. Characterization of the distribution, retention, and efficacy of internal radiation of (188)Re-lipid nanocapsules in an immunocompromised human glioblastoma model. Journal of Neuro-Oncology. PMID 27783195 DOI: 10.1007/S11060-016-2289-4 |
0.307 |
|
2015 |
Lemée JM, Clavreul A, Aubry M, Com E, de Tayrac M, Eliat PA, Henry C, Rousseau A, Mosser J, Menei P. Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis. Journal of Neuro-Oncology. 122: 53-61. PMID 25559687 DOI: 10.1007/S11060-014-1695-8 |
0.388 |
|
2015 |
Clavreul A, Etcheverry A, Tétaud C, Rousseau A, Avril T, Henry C, Mosser J, Menei P. Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins. Journal of Neuro-Oncology. 122: 1-10. PMID 25503303 DOI: 10.1007/S11060-014-1683-Z |
0.38 |
|
2014 |
Faguer R, Tanguy JY, Rousseau A, Clavreul A, Menei P. Early presentation of primary glioblastoma. Neuro-Chirurgie. 60: 188-93. PMID 24856049 DOI: 10.1016/J.Neuchi.2014.02.008 |
0.329 |
|
2014 |
Lainé AL, Clavreul A, Rousseau A, Tétaud C, Vessieres A, Garcion E, Jaouen G, Aubert L, Guilbert M, Benoit JP, Toillon RA, Passirani C. Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1667-77. PMID 24842766 DOI: 10.1016/J.Nano.2014.05.002 |
0.334 |
|
2014 |
Clavreul A, Guette C, Faguer R, Tétaud C, Boissard A, Lemaire L, Rousseau A, Avril T, Henry C, Coqueret O, Menei P. Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties. The Journal of Pathology. 233: 74-88. PMID 24481573 DOI: 10.1002/Path.4332 |
0.322 |
|
2014 |
Augereau P, Rousseau A, Michalak S, Pavageau A, Loussouarn D, Jadaud E, Nader E, Menei P, Soulie P. P17.03Post-Operative Exclusive Chemotherapy With Pcv For Anaplastic Oligodendroglioma: A Retrospective Study Of 35 Confirmed Cases Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou174.333 |
0.351 |
|
2012 |
Bielle F, Fréneaux P, Jeanne-Pasquier C, Maran-Gonzalez A, Rousseau A, Lamant L, Paris R, Pierron G, Nicolas AV, Sastre-Garau X, Delattre O, Bourdeaut F, Peuchmaur M. PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors. The American Journal of Surgical Pathology. 36: 1141-9. PMID 22790854 DOI: 10.1097/Pas.0B013E31825A6895 |
0.391 |
|
2012 |
Fèvre Montange M, Vasiljevic A, Bergemer Fouquet AM, Bernier M, Champier J, Chrétien F, Figarella-Branger D, Kemeny JL, Lechapt-Zalcman E, Michalak S, Miquel C, Mokthari K, Pommepuy I, Quintin Roué I, Rousseau A, et al. Histopathologic and ultrastructural features and claudin expression in papillary tumors of the pineal region: a multicenter analysis. The American Journal of Surgical Pathology. 36: 916-28. PMID 22588068 DOI: 10.1097/Pas.0B013E31824B7114 |
0.381 |
|
2011 |
Mohapatra G, Engler DA, Starbuck KD, Kim JC, Bernay DC, Scangas GA, Rousseau A, Batchelor TT, Betensky RA, Louis DN. Genome-wide comparison of paired fresh frozen and formalin-fixed paraffin-embedded gliomas by custom BAC and oligonucleotide array comparative genomic hybridization: facilitating analysis of archival gliomas. Acta Neuropathologica. 121: 529-43. PMID 21080181 DOI: 10.1007/S00401-010-0773-Z |
0.46 |
|
2011 |
Clarençon F, Bonneville F, Rousseau A, Galanaud D, Kujas M, Naggara O, Cornu P, Chiras J. Intracranial solitary fibrous tumor: imaging findings. European Journal of Radiology. 80: 387-94. PMID 20303226 DOI: 10.1016/J.Ejrad.2010.02.016 |
0.345 |
|
2010 |
Bikeye SN, Colin C, Marie Y, Vampouille R, Ravassard P, Rousseau A, Boisselier B, Idbaih A, Calvo CF, Leuraud P, Lassalle M, El Hallani S, Delattre JY, Sanson M. ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target. Cancer Cell International. 10: 1. PMID 20142996 DOI: 10.1186/1475-2867-10-1 |
0.386 |
|
2010 |
Rousseau A, Idbaih A, Ducray F, Crinière E, Fèvre-Montange M, Jouvet A, Delattre JY. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade. Journal of Neuro-Oncology. 97: 353-64. PMID 19865800 DOI: 10.1007/S11060-009-0039-6 |
0.355 |
|
2009 |
Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS lymphoma in immunocompetent patients. The Oncologist. 14: 526-39. PMID 19433528 DOI: 10.1634/Theoncologist.2008-0236 |
0.316 |
|
2008 |
Rodero M, Marie Y, Coudert M, Blondet E, Mokhtari K, Rousseau A, Raoul W, Carpentier C, Sennlaub F, Deterre P, Delattre JY, Debré P, Sanson M, Combadière C. Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5957-64. PMID 19001328 DOI: 10.1200/Jco.2008.17.2833 |
0.331 |
|
2008 |
Rousseau A, Mokhtari K, Duyckaerts C. The 2007 WHO classification of tumors of the central nervous system - what has changed? Current Opinion in Neurology. 21: 720-7. PMID 18989119 DOI: 10.1097/Wco.0B013E328312C3A7 |
0.361 |
|
2008 |
Ducray F, Benouaich-Amiel A, Idbaih A, Rousseau A, Laigle-Donadey F, Delattre JY, Sanson M. Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status. Journal of Neuro-Oncology. 88: 185-8. PMID 18317694 DOI: 10.1007/S11060-008-9546-0 |
0.306 |
|
2008 |
Idbaih A, Boisselier B, Marie Y, Sanson M, El Hallani S, Crinière E, Fourtassi M, Paris S, Carpentier C, Rousseau A, Mokhtari K, Combadière C, Laigle-Donadey F, Hoang-Xuan K, Delattre JY. Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors. Brain Research. 1198: 16-20. PMID 18262501 DOI: 10.1016/J.Brainres.2008.01.027 |
0.339 |
|
2006 |
Rousseau A, Nutt CL, Betensky RA, Iafrate AJ, Han M, Ligon KL, Rowitch DH, Louis DN. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2. Journal of Neuropathology and Experimental Neurology. 65: 1149-56. PMID 17146289 DOI: 10.1097/01.Jnen.0000248543.90304.2B |
0.635 |
|
2006 |
Rousseau A, Kujas M, Bergemer-Fouquet AM, van Effenterre R, Hauw JJ. Survivin expression in ganglioglioma. Journal of Neuro-Oncology. 77: 153-9. PMID 16292482 DOI: 10.1007/S11060-005-9033-9 |
0.374 |
|
2005 |
Rousseau A, Kujas M, van Effenterre R, Boch AL, Carpentier A, Leroy JP, Poirier J. Primary intracranial myopericytoma: report of three cases and review of the literature. Neuropathology and Applied Neurobiology. 31: 641-8. PMID 16281913 DOI: 10.1111/J.1365-2990.2005.00681.X |
0.302 |
|
2005 |
Rousseau A, Bernier M, Kujas M, Varlet P. Primary intracranial melanocytic tumor simulating pituitary macroadenoma: case report and review of the literature. Neurosurgery. 57: E369; discussion E36. PMID 16094139 DOI: 10.1227/01.Neu.0000166686.19823.A9 |
0.369 |
|
Show low-probability matches. |